PropertyValue
?:abstract
  • In response to the kind letter from Joaquin Cabezas et al. We agree that medical care in the COVID era has radically changed; using new mechanisms in the care of different diseases is undoubtedly now a priority to avoid contagion of both the patient and the medical staff, although the vaccine could protect the population, there are still many questions to answer; The model we use for the care of patients with a diagnosis of HCV in Mexico showed great benefits, as in other studies, since it significantly reduced costs, almost 50% of the patients were far from the center the third level but could be included, treated, monitored and cured using this model, with savings also in the complications that were avoided due to the non-progression of the disease and/or the stabilization of the already established liver disease, always based on guidelines international and national. This model could be used for other pathologies that require an evaluation and follow-up by specialists and subspecialists in populations far from tertiary hospitals. Even first contact doctors can be consulted, surely with extraordinary benefits in the final result of patient care, but especially now in the COVID era that requires greater protection for patients and health workers. We also agree with Dr. Javier Crespo\'s group that scientific societies and the governments of the countries are even more interested in supporting this type of care and generating the legal bases for this purpose.
?:creator
?:doi
  • 10.17235/reed.2021.7829/2021
?:doi
?:journal
  • Revista_espanola_de_enfermedades_digestivas_:_organo_oficial_de_la_Sociedad_Espanola_de_Patologia_Digestiva
?:license
  • unk
?:pmid
?:pmid
  • 33569965.0
?:publication_isRelatedTo_Disease
?:source
  • Medline
?:title
  • \'Chronic Viral Hepatitis C Micro-Elimination Program Using Telemedicine. The Mexican Experience\'.
?:type
?:year
  • 2021-02-11

Metadata

Anon_0  
expand all